Cargando…
Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229704/ https://www.ncbi.nlm.nih.gov/pubmed/36951993 http://dx.doi.org/10.1007/s00266-023-03306-1 |
| _version_ | 1785051328035160064 |
|---|---|
| author | Wu, Yan Fang, Fang Lai, Wei Li, Chengxin Li, Li Liu, Quanzhong Lu, Jianyun Pang, Xiaowen Sun, Jiaming Shi, Xiaofeng Picaut, Philippe Prygova, Inna Andriopoulos, Bill Sun, Qiuning |
| author_facet | Wu, Yan Fang, Fang Lai, Wei Li, Chengxin Li, Li Liu, Quanzhong Lu, Jianyun Pang, Xiaowen Sun, Jiaming Shi, Xiaofeng Picaut, Philippe Prygova, Inna Andriopoulos, Bill Sun, Qiuning |
| author_sort | Wu, Yan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10229704 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102297042023-06-01 Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study Wu, Yan Fang, Fang Lai, Wei Li, Chengxin Li, Li Liu, Quanzhong Lu, Jianyun Pang, Xiaowen Sun, Jiaming Shi, Xiaofeng Picaut, Philippe Prygova, Inna Andriopoulos, Bill Sun, Qiuning Aesthetic Plast Surg Correction Springer US 2023-03-23 2023 /pmc/articles/PMC10229704/ /pubmed/36951993 http://dx.doi.org/10.1007/s00266-023-03306-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Wu, Yan Fang, Fang Lai, Wei Li, Chengxin Li, Li Liu, Quanzhong Lu, Jianyun Pang, Xiaowen Sun, Jiaming Shi, Xiaofeng Picaut, Philippe Prygova, Inna Andriopoulos, Bill Sun, Qiuning Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study |
| title | Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study |
| title_full | Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study |
| title_fullStr | Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study |
| title_full_unstemmed | Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study |
| title_short | Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study |
| title_sort | correction: efficacy and safety of abobotulinumtoxina for the treatment of glabellar lines in chinese patients: a pivotal, phase 3, randomized, double-blind and open-label phase study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229704/ https://www.ncbi.nlm.nih.gov/pubmed/36951993 http://dx.doi.org/10.1007/s00266-023-03306-1 |
| work_keys_str_mv | AT wuyan correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT fangfang correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT laiwei correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT lichengxin correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT lili correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT liuquanzhong correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT lujianyun correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT pangxiaowen correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT sunjiaming correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT shixiaofeng correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT picautphilippe correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT prygovainna correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT andriopoulosbill correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy AT sunqiuning correctionefficacyandsafetyofabobotulinumtoxinaforthetreatmentofglabellarlinesinchinesepatientsapivotalphase3randomizeddoubleblindandopenlabelphasestudy |